-

Lawyers for Johnson & Johnson’s Ovarian Cancer Victims React to SCOTUS Decision in Purdue

Beasley Allen: ‘We believe this decision should spell doom for J&J’s third bankruptcy plan’

WASHINGTON--(BUSINESS WIRE)--The U.S. Supreme Court has denied a $7 billion Purdue Pharmaceuticals bankruptcy plan which would have given the Sackler family, which founded the company, immunity from additional liability for their irresponsible actions in promoting the deadly use of opioids to the public and physicians.

The Sackler family had agreed to provide up to $6 billion in funding in exchange for immunity from further legal action while protecting billions in other assets. But the court ruled 5-4 that bankruptcy law does not permit that kind of protection.

The decision has significant implications for ongoing efforts by Johnson & Johnson (NYSE:JNJ) to seek bankruptcy protection in an effort to resolve tens of thousands of ovarian cancer claims tied to the use of the company’s talc-based products, including the Johnson’s Baby Powder and Shower to Shower brands.

In response, the following is a statement from Leigh O’Dell of the Beasley Allen Law Firm and Co-Chair of the Plaintiffs’ Steering Committee in the Talc/Ovarian Cancer MDL in New Jersey Federal Court.

“We believe this decision should spell doom for J&J’s third bankruptcy plan. Today’s ruling affirms that financially solvent entities, or individuals, cannot use the bankruptcy courts as a shield to escape liability for marketing and manufacturing dangerous products.

“The parallels of this case with J&J’s continued and unsuccessful attempts to use the bankruptcy laws to mirror the fraud perpetrated by the Sackler family cannot be denied. Even with an overwhelming majority of creditors approving the Sacklers’ indemnification scheme, the principles of fundamental fairness -- that it is the debtor who may receive the benefits of bankruptcy not other wrongdoers (such as the Sacklers or J&J) -- have been upheld.

“We hope that this decision provides clarity to the controversy that resulted in rampant forum shopping by companies and inconsistent administration of the code by the courts. We also hope that this decision will derail any attempt by J&J to return the talc litigation to the bankruptcy courts, and we can continue to move forward with trials that support the constitutional rights of our clients and resolutions that consider the true financial and emotional toll suffered by thousands of J&J’s victims.

“J&J’s response to today’s Supreme Court ruling in the Sackler case reveals a half-trillion-dollar company still desperate to use bankruptcy as a shield to protect itself from the tens of thousands of women who have cancer only because they used Johnson’s Baby Powder or Shower to Shower. It won’t work.

“Despite mountains of evidence to the contrary, J&J continues to mislead juries and members of the public by claiming talc-based baby powder doesn’t contain asbestos. Yet, at the same time, J&J seeks the shelter of a bankruptcy escape hatch that Congress designed exclusively for asbestos-containing products. They can’t have it both ways. It’s time for J&J to abandon its hysterical, bullying, and untruthful rhetoric and act as a responsible corporation.”

Contacts

Mike Androvett
800-559-4534
mike@androvett.com

Beasley Allen

NYSE:JNJ

Release Versions

Contacts

Mike Androvett
800-559-4534
mike@androvett.com

More News From Beasley Allen

California Jury Awards $40 Million in Landmark Talc Verdict Against Johnson & Johnson

LOS ANGELES--(BUSINESS WIRE)--A Los Angeles Superior Court jury on Friday delivered a $40 million verdict against Johnson & Johnson. The trial involved two women who developed ovarian cancer after decades of using the company's talc-based baby powder products. The award to plaintiffs Monica Kent and Deborah Schultz, and her husband, Dr. Albert Schultz, totals $40 million in compensatory damages. The California trial is the first of 10 or more trials expected through the first half of 2026 i...

California Jury Awards $40 Million in Landmark Talc Verdict Against Johnson & Johnson

LOS ANGELES--(BUSINESS WIRE)--A Los Angeles Superior Court jury today delivered a $40 million verdict against Johnson & Johnson. The trial featured two California women who developed ovarian cancer after decades of using the company's talc-based baby powder products. The award to plaintiffs Monica Kent and Deborah Schultz, and her husband, Dr. Albert Schultz, totals $40 million in compensatory damages. The verdict followed a four-week trial that featured testimony from former United States...

FDA Panel Reiterates the Cancer Risks of Talc

WASHINGTON--(BUSINESS WIRE)--A panel of medical experts convened by the U.S. Food & Drug Administration urged the agency to study and adopt new standards to prohibit the use of talc in consumer products such as gum, candy, rice and pharmaceuticals. Many of the experts cited the more than 30 years of studies showing an association between talc use and ovarian cancer, which led Johnson & Johnson (NYSE:JNJ) to remove the company’s iconic body powders from the market in recent years. “It’s...
Back to Newsroom